Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis
Fibroblast Growth Factor 19 (FGF19) neutralizing antibodies inhibit hepatocellular carcinoma (HCC) growth but have safety issues. Here, the authors show that FGF19 promotes HCC by activating STAT3 signalling via IL-6 production and that targeting IL-6 pathway abolishes FGF19-induced HCC without side...
Guardado en:
Autores principales: | Mei Zhou, Hong Yang, R. Marc Learned, Hui Tian, Lei Ling |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1666989d05a642a7880186e1fdbad158 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A cell-autonomous tumour suppressor role of RAF1 in hepatocarcinogenesis
por: Ines Jeric, et al.
Publicado: (2016) -
Downregulation of Renal MRPs Transporters in Acute Lymphoblastic Leukemia Mediated by the IL-6/STAT3/PXR Signaling Pathway
por: Zhou Y, et al.
Publicado: (2021) -
Apoptotic stress-induced FGF signalling promotes non-cell autonomous resistance to cell death
por: Florian J. Bock, et al.
Publicado: (2021) -
Novel STAT binding elements mediate IL-6 regulation of MMP-1 and MMP-3
por: Samuel J. Cutler, et al.
Publicado: (2017) -
Iron overload inhibits BMP/SMAD and IL-6/STAT3 signaling to hepcidin in cultured hepatocytes.
por: Edouard Charlebois, et al.
Publicado: (2021)